Renal denervation: Current implications and future perspectives

Clinical Science

Volumn 126, Issue 1, 2014, Pages 41-53

  Xu, Jianzhong ^a   Hering, Dagmara ^a,b   Sata, Yusuke ^a   Walton, Antony ^c   Krum, Henry ^c,d   Esler, Murray D ^a,c   Schlaich, Markus P ^a,c,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c ALFRED HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Augmentation index; Blood pressure; Renal denervation; Resistant hypertension; Sympathetic nerve activity

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE REGULATION; CATHETER ABLATION; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY DENERVATION; KIDNEY FAILURE; KIDNEY NERVE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; RISK ASSESSMENT; SENSORY NERVE; SYMPATHETIC NERVE; TREATMENT INDICATION;

CATHETER ABLATION; CORONARY VASOSPASM; HUMANS; HYPERTENSION; INSULIN RESISTANCE; KIDNEY; KIDNEY FAILURE, CHRONIC; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84885024653     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120581     Document Type: Article

References (92)

1. Esler, M. (2011) The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp. Physiol. 96, 611-622
2. Ackerknecht, E. H. (1974) The history of the discovery of the vegatative (autonomic) nervous system. Med. Hist. 18, 1-8
3. Adrian, E. D., Bronk, D. W. and Phillips, G. (1932) Discharges in mammalian sympathetic nerves. J. Physiol. 74, 115-133
4. Von Euler, U. S. (1946) A substance with sympathin E properties in spleen extracts. Nature 157, 369
5. Cannon, W. B. (1933) Chemical mediators of autonomic nerve impulses. Science 78, 43-48
6. DiBona, G. F., and Kopp, U. C. (1997) Neural control of renal function. Physiol. Rev. 77, 75-197
7. Schlaich, M. P., Lambert, E., Kaye, D. M., Krozowski, Z., Campbell, D. J., Lambert, G., Hastings, J., Aggarwal, A., and Esler, M. D. (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43, 169-175
8. Grewal, R. S., and Kaul, C. L. (1971) Importance of the sympathetic nervous system in the development of renal hypertension in the rat. Br. J. Pharmacol. 42, 497-504
9. Smith,P. A., Graham, L. N., Mackintosh, A. F., Stoker, J. B., and Mary, D. A. (2004) Relationship between central sympathetic activity and stages of human hypertension. Am. J. Hypertens. 17, 217-222
10. Masuo, K., Rakugi, H., Ogihara, T., Esler, M. D., and Lambert, G. W. (2010) Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr. Diabetes Rev. 6, 58-67
11. Cohn, J. N., Levine, T. B., Francis, G. S., and Goldsmith, S. (1981) Neurohumoral control mechanisms in congestive heart failure. Am. Heart J. 102, 509-514
12. Grassi, G., Quarti-Trevano, F., Seravalle, G., Arenare, F., Volpe, M., Furiani, S., Dell'Oro, R., and Mancia, G. (2011) Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57, 846-851
13. Bertog, S. C., Sobotka, P. A., and Sievert, H. (2012) Renal denervation for hypertension. JACC Cardiovasc. Interv. 5, 249-258
14. Barajas, L., Liu, L., and Powers, K. (1992) Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can. J. Physiol. Pharmacol. 70, 735-749
15. Barajas, L., and Powers, K. V. (1988) Innervation of the thick ascending limb of Henle. Am. J. Physiol. 255, F340-F348
16. Barajas, L., Powers, K., and Wang, P. (1985) Innervation of the late distal nephron: an autoradiographic and ultrastructural study. J. Ultrastruct. Res. 92, 146-157
17. Barajas, L., and Muller, J. (1973) The innervation of the juxtaglomerular apparatus and surrounding tubules: a quantitative analysis by serial section electron microscopy. J. Ultrastruct. Res. 43, 107-132
18. Kopp, U. C., Cicha, M. Z., Smith, L. A., Mulder, J., and Hokfelt, T. (2007) Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of a1- and a2-adrenoceptors on renal sensory nerve fibers. Am J. Physiol. Regul. Integr. Comp. Physiol. 293, R1561-R1572
19. DiBona, G. F. (2000) Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36, 1083-1088
20. Zanchetti, A. S. (1977) Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Circulation 56, 691-698
21. Bell-Reuss, E., Trevino, D. L., and Gottschalk, C. W. (1976) Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J. Clin. Invest. 57, 1104-1107
22. Kirchheim, H., Ehmke, H., and Persson, P. (1989) Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin. Wochenschr. 67, 858-864
23. Weiss, M. L., and Chowdhury, S. I. (1998) The renal afferent pathways in the rat: a pseudorabies virus study. Brain Res. 812, 227-241
24. Liu, L., and Barajas, L. (1993) The rat renal nerves during development. Anat. Embryol. 188, 345-361
25. Genovesi, S., Pieruzzi, F., Wijnmaalen, P., Centonza, L., Golin, R., Zanchetti, A., and Stella, A. (1993) Renal afferents signaling diuretic activity in the cat. Circ. Res. 73, 906-913
26. Morsing, P., and Persson, A. E. (1990) Pelvic pressure and tubuloglomerular feedback in hydronephrosis. Renal Physiol. Biochem. 13, 181-189
27. Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., and Lambert, E. (2006) Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796
28. Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., and Mancia, G. (1998) Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31, 68-72
29. Esler, M., Jennings, G., Biviano, B., Lambert, G., and Hasking, G. (1986) Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J. Cardiovasc. Pharmacol. 8 (Suppl. 5), S39-S43
30. Esler, M., Jennings, G., and Lambert, G. (1989) Noradrenaline release and the pathophysiology of primary human hypertension. Am. J. Hypertens. 2, 140S-146S
31. Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., and Esler, M. D. (2003) Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108, 560-565
32. Anderson, E. A., Sinkey, C. A., Lawton, W. J., and Mark, A. L. (1989) Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14, 177-183
33. Kon, V. (1989) Neural control of renal circulation. Miner. Electrolyte Metab. 15, 33-43
34. Surtshin, A., Mueller, C. B., and White, H. L. (1952) Effect of acute changes in glomerular filtration rate on water and electrolyte excretion; mechanism of denervation diuresis. Am. J. Physiol. 169, 159-173
35. Kamm, D. E., and Levinsky, N. G. (1965) The mechanism of denervation natriuresis. J. Clin. Invest. 44, 93-102
36. Bello-Reuss, E., Colindres, R. E., Pastoriza-Munoz, E., Mueller, R. A., and Gottschalk, C. W. (1975) Effects of acute unilateral renal denervation in the rat. J. Clin. Invest. 56, 208-217
37. Parkes, W. E. (1958) Thoracolumbar sympathectomy in hypertension. Br. Heart J. 20, 249-252
38. Newcombe, C. P., Shucksmith, H. S., and Suffern, W. S. (1959) Sympathectomy for hypertension; follow-up of 212 patients. Br. Med. J. 1, 142-144
39. Peet, M. M. (1947) Results of bilateral supradiaphragmatic splanchnicectomy for arterial hypertension. N. Engl. J. Med. 236, 270-277
40. Abbott, A. C. (1952) The surgical treatment of hypertension; 17 years in retrospect. Can. Med. Assoc. J. 66, 211-214
41. Smithwick, R. H., and Thompson, J. E. (1953) Splanchnicectomy for essential hypertension; results in 1,266 cases. JAMA, J. Am. Med. Assoc. 152, 1501-1504
42. Smithwick, R. H. (1955) Hypertensive vascular disease; results of and indications for splanchnicectomy. J. Chronic Dis. 1, 477-496
43. Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S. et al. (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275-1281
44. Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57, 911-917
45. Esler, M. D., Krum, H., Sobotka, P. A., Schlaich, M. P., Schmieder, R. E., and Bohm, M. (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376, 1903-1909
46. Vonend, O., Antoch, G., Rump, L. C., and Blondin, D. (2012) Secondary rise in blood pressure after renal denervation. Lancet 380, 778
47. Esler, M. D., Krum, H., Schlaich, M., Schmieder, R. E., Bohm, M., and Sobotka, P. A. (2012) Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 126, 2976-2982
48. Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Bohm, M., and Hoppe, U. C. (2012) Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J. Am. Coll. Cardiol. 59, 901-909
49. Persu, A., Renkin, J., Thijs, L., and Staessen, J. A. (2012) Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension 60, 596-606
50. Brinkmann, J., Heusser, K., Schmidt, B. M., Menne, J., Klein, G., Bauersachs, J., Haller, H., Sweep, F. C., Diedrich, A., Jordan, J., and Tank, J. (2012) Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension 60, 1485-1490
51. Schlaich, M., Hering, D., Lambert, G., Lambert, E., and Esler, M. (2013) Blood pressure and sympathetic nervous system response to renal denervation. Hypertension 61, e13
52. Petersson, M. J., Rundqvist, B., Johansson, M., Eisenhofer, G., Lambert, G., Herlitz, H., Jensen, G., and Friberg, P. (2002) Increased cardiac sympathetic drive in renovascular hypertension. J. Hypertens. 20, 1181-1187
53. Converse, Jr, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M., Cosentino, F., Fouad-Tarazi, F., and Victor, R. G. (1992) Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med. 327, 1912-1918
54. Amann, K., Koch, A., Hofstetter, J., Gross, M. L., Haas, C., Orth, S. R., Ehmke, H., Rump, L. C., and Ritz, E. (2001) Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. Kidney Int. 60, 1309-1323
55. Amann, K., Rump, L. C., Simonaviciene, A., Oberhauser, V., Wessels, S., Orth, S. R., Gross, M. L., Koch, A., Bielenberg, G. W., Van Kats, J. P. et al. (2000) Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J. Am. Soc. Nephrol. 11, 1469-1478
56. Mahfoud, F., Cremers, B., Janker, J., Link, B., Vonend, O., Ukena, C., Linz, D., Schmieder, R., Rump, L. C., Kindermann, I. et al. (2012) Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 60, 419-424
57. Hering, D., Mahfoud, F., Walton, A. S., Krum, H., Lambert, G. W., Lambert, E. A., Sobotka, P. A., Bohm, M., Cremers, B., Esler, M. D., and Schlaich, M. P. (2012) Renal denervation in moderate to severe CKD. J. Am. Soc. Nephrol. 23, 1250-1257
58. Lilley, J. J., Golden, J., and Stone, R. A. (1976) Adrenergic regulation of blood pressure in chronic renal failure. J. Clin. Invest. 57, 1190-1200
59. Degli Esposti, E., Sturani, A., Santoro, A., Zuccala, A., Chiarini, C., and Zucchelli, P. (1985) Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients. Clin. Sci. 69, 51-56
60. Schlaich, M. P., Socratous, F., Hennebry, S., Eikelis, N., Lambert, E. A., Straznicky, N., Esler, M. D., and Lambert, G. W. (2009) Sympathetic activation in chronic renal failure. J. Am. Soc. Nephrol. 20, 933-939
61. Schlaich, M. P., Bart, B., Hering, D., Walton, A., Marusic, P., Mahfoud, F., Bohm, M., Lambert, E. A., Krum, H., Sobotka, P. A. et al. (2013) Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int. J. Cardiol., doi: 10.1016/j.ijcard.2013.01.218
62. Floras, J. S. (1993) Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J. Am. Coll. Cardiol. 22, 72A-84A
63. Petersson, M., Friberg, P., Eisenhofer, G., Lambert, G., and Rundqvist, B. (2005) Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur. Heart J. 26, 906-913
64. Sobotka, P. A., Krum, H., Bohm, M., Francis, D. P., and Schlaich, M. P. (2012) The role of renal denervation in the treatment of heart failure. Curr. Cardiol. Rep. 14, 285-292
65. Villarreal, D., Freeman, R. H., Johnson, R. A., and Simmons, J. C. (1994) Effects of renal denervation on postprandial sodium excretion in experimental heart failure. Am. J. Physiol. 266, R1599-R1604
66. Davies, J. E., Manisty, C. H., Petraco, R., Barron, A. J., Unsworth, B., Mayet, J., Hamady, M., Hughes, A. D., Sever, P. S., Sobotka, P. A., and Francis, D. P. (2013) First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int. J. Cardiol. 162, 189-192
67. Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., and Brant, D. O. (1993) Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21, 618-623
68. Laakso, M., Edelman, S. V., Brechtel, G., and Baron, A. D. (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J. Clin. Invest. 85, 1844-1852
69. Mahfoud, F., Schlaich, M., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A. et al. (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123, 1940-1946
70. Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S., and Bradley, T. D. (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens. 19, 2271-2277
71. Baguet, J. P., Barone-Rochette, G., and Pepin, J. L. (2009) Hypertension and obstructive sleep apnoea syndrome: current perspectives. J. Hum. Hypertens. 23, 431-443
72. Ruttanaumpawan, P., Nopmaneejumruslers, C., Logan, A. G., Lazarescu, A., Qian, I., and Bradley, T. D. (2009) Association between refractory hypertension and obstructive sleep apnea. J. Hypertens. 27, 1439-1445
73. Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S. et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105-1187
74. Narkiewicz, K., and Somers, V. K. (2003) Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol. Scand. 177, 385-390
75. Witkowski, A., Prejbisz, A., Florczak, E., Kadziela, J., Sliwinski, P., Bielen, P., Michalowska, I., Kabat, M., Warchol, E., Januszewicz, M. et al. (2011) Effects of renal sympathetic denervation on blood pressure, sleep apnea course and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58, 559-565
76. Friedman, O., Bradley, T. D., Chan, C. T., Parkes, R., and Logan, A. G. (2010) Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 56, 1077-1082
77. Pang, C. C. (2001) Autonomic control of the venous system in health and disease: effects of drugs. Pharmacol. Ther. 90, 179-230
78. Chen, P. S., and Tan, A. Y. (2007) Autonomic nerve activity and atrial fibrillation. Heart Rhythm 4, S61-S64
79. Sharifov, O. F., Fedorov, V. V., Beloshapko, G. G., Glukhov, A. V., Yushmanova, A. V., and Rosenshtraukh, L. V. (2004) Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J. Am. Coll. Cardiol. 43, 483-490
80. Shen, M. J., Choi, E. K., Tan, A. Y., Han, S., Shinohara, T., Maruyama, M., Chen, L. S., Shen, C., Hwang, C., Lin, S. F., and Chen, P. S. (2011) Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fibrillation. Heart Rhythm 8, 583-589
81. Huang, J. L., Wen, Z. C., Lee, W. L., Chang, M. S., and Chen, S. A. (1998) Changes of autonomic tone before the onset of paroxysmal atrial fibrillation. Int. J. Cardiol. 66, 275-283
82. Dimmer, C., Tavernier, R., Gjorgov, N., Van Nooten, G., Clement, D. L., and Jordaens, L. (1998) Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am. J. Cardiol. 82, 22-25
83. Wen, Z. C., Chen, S. A., Tai, C. T., Huang, J. L., and Chang, M. S. (1998) Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter. J. Am. Coll. Cardiol. 31, 602-607
84. Pokushalov, E., Romanov, A., Corbucci, G., Artyomenko, S., Baranova, V., Turov, A., Shirokova, N., Karaskov, A., Mittal, S., and Steinberg, J. S. (2012) A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J. Am. Coll. Cardiol. 60, 1163-1170
85. Ahmed, H., Neuzil, P., Skoda, J., Petru, J., Sediva, L., Schejbalova, M., and Reddy, V. Y. (2012) Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. JACC Cardiovasc. Interv. 5, 758-765
86. Penn, M. S., Ellis, S., Gandhi, S., Greenbaum, A., Hodes, Z., Mendelsohn, F. O., Strasser, D., Ting, A. E., and Sherman, W. (2012) Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ. Res. 110, 304-311
87. Hering, D., Lambert, E. A., Marusic, P., Walton, A. S., Krum, H., Lambert, G. W., Esler, M. D., and Schlaich, M. P. (2013) Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 61, 457-464
88. Brandt, M. C., Reda, S., Mahfoud, F., Lenski, M., Bohm, M., and Hoppe, U. C. (2012) Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J. Am. Coll. Cardiol. 60, 1956-1965
89. Ukena, C., Mahfoud, F., Kindermann, I., Barth, C., Lenski, M., Kindermann, M., Brandt, M. C., Hoppe, U. C., Krum, H., Esler, M. et al. (2011) Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J. Am. Coll. Cardiol. 58, 1176-1182
90. Kandzari, D. E., Bhatt, D. L., Sobotka, P. A., O'Neill, W. W., Esler, M., Flack, J. M., Katzen, B. T., Leon, M. B., Massaro, J. M., Negoita, M. et al. (2012) Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin. Cardiol. 35, 528-535
91. Ukena, C., Bauer, A., Mahfoud, F., Schreieck, J., Neuberger, H. R., Eick, C., Sobotka, P. A., Gawaz, M., and Bohm, M. (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin. Res. Cardiol. 101, 63-67
92. Schlaich, M. P., Straznicky, N., Grima, M., Ika-Sari, C., Dawood, T., Mahfoud, F., Lambert, E., Chopra, R., Socratous, F., Hennebry, S. et al. (2011) Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J. Hypertens. 29, 991-996